- Home
- ICLR vs AVY Comparison
ICLR vs AVY Comparison
Compare ICLR & AVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- AVY
- Stock Information
- Founded
- ICLR 1990
- AVY 1935
- Country
- ICLR Ireland
- AVY United States
- Employees
- ICLR N/A
- AVY N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- AVY Containers/Packaging
- Sector
- ICLR Health Care
- AVY Consumer Discretionary
- Exchange
- ICLR Nasdaq
- AVY Nasdaq
- Market Cap
- ICLR 13.7B
- AVY 13.1B
- IPO Year
- ICLR 1998
- AVY N/A
- Fundamental
- Price
- ICLR $175.00
- AVY $165.66
- Analyst Decision
- ICLR Buy
- AVY Buy
- Analyst Count
- ICLR 15
- AVY 10
- Target Price
- ICLR $209.93
- AVY $197.00
- AVG Volume (30 Days)
- ICLR 1.0M
- AVY 546.7K
- Earning Date
- ICLR 10-22-2025
- AVY 10-22-2025
- Dividend Yield
- ICLR N/A
- AVY 2.27%
- EPS Growth
- ICLR 13.11
- AVY 14.63
- EPS
- ICLR 9.73
- AVY 8.92
- Revenue
- ICLR $8,089,820,000.00
- AVY $8,737,900,000.00
- Revenue This Year
- ICLR N/A
- AVY $2.20
- Revenue Next Year
- ICLR $1.73
- AVY $3.95
- P/E Ratio
- ICLR $17.99
- AVY $18.57
- Revenue Growth
- ICLR N/A
- AVY 1.66
- 52 Week Low
- ICLR $125.10
- AVY $157.00
- 52 Week High
- ICLR $310.54
- AVY $224.38
- Technical
- Relative Strength Index (RSI)
- ICLR 53.09
- AVY 39.51
- Support Level
- ICLR $164.00
- AVY $164.30
- Resistance Level
- ICLR $180.95
- AVY $168.86
- Average True Range (ATR)
- ICLR 6.38
- AVY 2.83
- MACD
- ICLR -0.99
- AVY -0.46
- Stochastic Oscillator
- ICLR 64.59
- AVY 9.64
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About AVY Avery Dennison Corporation
Avery Dennison manufactures pressure-sensitive materials, merchandise tags, and labels. The company also runs a specialty converting business that produces radio-frequency identification inlays and labels. Avery Dennison draws a significant amount of revenue from outside the United States, with international operations accounting for the majority of total sales.